Why no Xeljanz DTC?

Discussion in 'Pfizer' started by Anonymous, May 8, 2013 at 8:46 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    The value proposition of Xeljanz rests with the availability of oral. That's it. Not the efficacy without the 10mg. Never going to be the safety or the AEs. It's the oral.

    Why then, are you guys waiting so long to frame value in messages to the public?

    When the general public realizes that there's a oral option available, only then will your product humm.

    So, when can we expect it?
     

  2. Anonymous

    Anonymous Guest

    WHEN THE THE FDA APPROVES EVERYTHING
     
  3. Anonymous

    Anonymous Guest

    Why no sales? 11 million, joke!
     
  4. Anonymous

    Anonymous Guest

    Don't know where you got your numbers from, we're not at goal, but we're closer to 40 million.
    We still got a chance at Hawaii (NOT)